Omnicell Investor Presentation Deck slide image

Omnicell Investor Presentation Deck

3 Advanced Services Accelerating Recurring Revenue Growth Advanced Services (% of Total Revenue) 6% 2020 10% 2021 Targeting 18% of total revenue for 2023 14% 2022 18% 2023E NOTE: Includes Central Pharmacy Dispensing Service (service portion), IV Compounding Service (service portion), EnlivenHealth solutions, Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, and other software solutions. © 2023 Omnicell, Inc. Leveraging established channels and strong customer relationships Strong demand driven by increasing provider digitization and need to evolve medication supply chain Omnicell's cloud-based services designed to enable better outcomes Subscription-based, recurring revenue streams Advanced Services expand our TAM 10
View entire presentation